Paclitaxel-loaded ROS-responsive nanoparticles for head and neck cancer therapy

Paclitaxel-loaded ROS-responsive nanoparticles for head and neck cancer therapy

AbstractHigh intracellular reactive oxygen species (ROS) level is characteristic of cancer cells and could act as a target for the efficient targeted drug delivery for cancer treatment. Consequently, biomaterials that react to excessive levels of ROS are essential for biomedical applications. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yaqin Tu, Wei Zhang, Guorun Fan, Chenming Zou, Jie Zhang, Nan Wu, Jiahui Ding, Wen Qing Zou, Hongjun Xiao, Songwei Tan
Formato: Artículo
Lenguaje:English
Publicado: Taylor & Francis Group 2023-12-01
Colección:Drug Delivery
Materias:
ROS
head and neck cancer
paclitaxel
controlled release
targeting
Acceso en línea:https://www.tandfonline.com/doi/10.1080/10717544.2023.2189106

Internet

https://www.tandfonline.com/doi/10.1080/10717544.2023.2189106

Ejemplares similares